Joel Isaacson & Co’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q2
Sell
-2
Closed 748
2016
Q1
$0 Buy
+2
New ﹤0.01% 779